nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclophosphamide—CYP2A6—Fluorouracil—head and neck cancer	0.117	0.189	CbGbCtD
Cyclophosphamide—CYP2D6—Hydroxyurea—head and neck cancer	0.0967	0.156	CbGbCtD
Cyclophosphamide—CYP3A7—Docetaxel—head and neck cancer	0.0613	0.0987	CbGbCtD
Cyclophosphamide—CYP3A7-CYP3A51P—Docetaxel—head and neck cancer	0.0613	0.0987	CbGbCtD
Cyclophosphamide—CYP2C8—Fluorouracil—head and neck cancer	0.0579	0.0932	CbGbCtD
Cyclophosphamide—CYP3A5—Docetaxel—head and neck cancer	0.046	0.074	CbGbCtD
Cyclophosphamide—CYP2C9—Fluorouracil—head and neck cancer	0.0404	0.065	CbGbCtD
Cyclophosphamide—ABCB1—Vinblastine—head and neck cancer	0.0363	0.0585	CbGbCtD
Cyclophosphamide—CYP2D6—Vinblastine—head and neck cancer	0.0342	0.0551	CbGbCtD
Cyclophosphamide—ABCB1—Docetaxel—head and neck cancer	0.0299	0.0482	CbGbCtD
Cyclophosphamide—CYP3A4—Vinblastine—head and neck cancer	0.0218	0.035	CbGbCtD
Cyclophosphamide—CYP3A4—Docetaxel—head and neck cancer	0.0179	0.0289	CbGbCtD
Cyclophosphamide—Interstitial pneumonia—Docetaxel—head and neck cancer	0.00138	0.00399	CcSEcCtD
Cyclophosphamide—Hepatic enzyme increased—Hydroxyurea—head and neck cancer	0.00135	0.00393	CcSEcCtD
Cyclophosphamide—Ulcer—Hydroxyurea—head and neck cancer	0.00135	0.00393	CcSEcCtD
Cyclophosphamide—Blood uric acid increased—Hydroxyurea—head and neck cancer	0.0013	0.00378	CcSEcCtD
Cyclophosphamide—Blister—Fluorouracil—head and neck cancer	0.00128	0.00371	CcSEcCtD
Cyclophosphamide—Neoplasm—Vinblastine—head and neck cancer	0.00127	0.00368	CcSEcCtD
Cyclophosphamide—Menstruation irregular—Docetaxel—head and neck cancer	0.0012	0.00348	CcSEcCtD
Cyclophosphamide—Systemic lupus erythematosus—Docetaxel—head and neck cancer	0.0012	0.00348	CcSEcCtD
Cyclophosphamide—Mucosal inflammation—Docetaxel—head and neck cancer	0.0012	0.00348	CcSEcCtD
Cyclophosphamide—Phlebitis—Vinblastine—head and neck cancer	0.00118	0.00343	CcSEcCtD
Cyclophosphamide—Necrosis—Fluorouracil—head and neck cancer	0.00117	0.00341	CcSEcCtD
Cyclophosphamide—Neoplasm—Hydroxyurea—head and neck cancer	0.00116	0.00336	CcSEcCtD
Cyclophosphamide—Pulmonary oedema—Hydroxyurea—head and neck cancer	0.00114	0.00331	CcSEcCtD
Cyclophosphamide—Deafness—Vinblastine—head and neck cancer	0.00114	0.0033	CcSEcCtD
Cyclophosphamide—Lacrimation—Docetaxel—head and neck cancer	0.00113	0.00328	CcSEcCtD
Cyclophosphamide—Skin hyperpigmentation—Docetaxel—head and neck cancer	0.00112	0.00324	CcSEcCtD
Cyclophosphamide—Febrile neutropenia—Docetaxel—head and neck cancer	0.0011	0.00321	CcSEcCtD
Cyclophosphamide—Tenderness—Fluorouracil—head and neck cancer	0.00106	0.00306	CcSEcCtD
Cyclophosphamide—Extravasation—Fluorouracil—head and neck cancer	0.00106	0.00306	CcSEcCtD
Cyclophosphamide—Embolism—Docetaxel—head and neck cancer	0.00104	0.00301	CcSEcCtD
Cyclophosphamide—Hepatic failure—Hydroxyurea—head and neck cancer	0.00103	0.003	CcSEcCtD
Cyclophosphamide—Nail disorder—Docetaxel—head and neck cancer	0.00102	0.00297	CcSEcCtD
Cyclophosphamide—Parosmia—Docetaxel—head and neck cancer	0.00102	0.00297	CcSEcCtD
Cyclophosphamide—Renal failure acute—Hydroxyurea—head and neck cancer	0.00101	0.00292	CcSEcCtD
Cyclophosphamide—Lacrimation increased—Fluorouracil—head and neck cancer	0.000999	0.0029	CcSEcCtD
Cyclophosphamide—Redness—Docetaxel—head and neck cancer	0.000985	0.00286	CcSEcCtD
Cyclophosphamide—Ulcer—Fluorouracil—head and neck cancer	0.000974	0.00283	CcSEcCtD
Cyclophosphamide—Dermatitis bullous—Hydroxyurea—head and neck cancer	0.000972	0.00282	CcSEcCtD
Cyclophosphamide—Neuralgia—Docetaxel—head and neck cancer	0.000957	0.00278	CcSEcCtD
Cyclophosphamide—Inflammation—Fluorouracil—head and neck cancer	0.000949	0.00276	CcSEcCtD
Cyclophosphamide—Interstitial lung disease—Docetaxel—head and neck cancer	0.000939	0.00273	CcSEcCtD
Cyclophosphamide—Pleural effusion—Docetaxel—head and neck cancer	0.000868	0.00252	CcSEcCtD
Cyclophosphamide—Hepatotoxicity—Docetaxel—head and neck cancer	0.000861	0.0025	CcSEcCtD
Cyclophosphamide—Necrosis—Docetaxel—head and neck cancer	0.000847	0.00246	CcSEcCtD
Cyclophosphamide—Pancytopenia—Vinblastine—head and neck cancer	0.000836	0.00243	CcSEcCtD
Cyclophosphamide—Rhinorrhoea—Docetaxel—head and neck cancer	0.00082	0.00238	CcSEcCtD
Cyclophosphamide—Sepsis—Fluorouracil—head and neck cancer	0.000799	0.00232	CcSEcCtD
Cyclophosphamide—Acute coronary syndrome—Vinblastine—head and neck cancer	0.000774	0.00225	CcSEcCtD
Cyclophosphamide—Neuropathy peripheral—Vinblastine—head and neck cancer	0.000769	0.00223	CcSEcCtD
Cyclophosphamide—Myocardial infarction—Vinblastine—head and neck cancer	0.000769	0.00223	CcSEcCtD
Cyclophosphamide—Pancytopenia—Hydroxyurea—head and neck cancer	0.000762	0.00221	CcSEcCtD
Cyclophosphamide—Extravasation—Docetaxel—head and neck cancer	0.000762	0.00221	CcSEcCtD
Cyclophosphamide—Swelling—Fluorouracil—head and neck cancer	0.000758	0.0022	CcSEcCtD
Cyclophosphamide—Amenorrhoea—Docetaxel—head and neck cancer	0.000757	0.0022	CcSEcCtD
Cyclophosphamide—Agranulocytosis—Vinblastine—head and neck cancer	0.000732	0.00213	CcSEcCtD
Cyclophosphamide—Oropharyngeal pain—Docetaxel—head and neck cancer	0.000731	0.00212	CcSEcCtD
Cyclophosphamide—Hyperbilirubinaemia—Docetaxel—head and neck cancer	0.000731	0.00212	CcSEcCtD
Cyclophosphamide—Weight increased—Hydroxyurea—head and neck cancer	0.000731	0.00212	CcSEcCtD
Cyclophosphamide—Lacrimation increased—Docetaxel—head and neck cancer	0.000721	0.00209	CcSEcCtD
Cyclophosphamide—Drug interaction—Docetaxel—head and neck cancer	0.000717	0.00208	CcSEcCtD
Cyclophosphamide—Haemoglobin—Vinblastine—head and neck cancer	0.000708	0.00206	CcSEcCtD
Cyclophosphamide—Haemorrhage—Vinblastine—head and neck cancer	0.000705	0.00204	CcSEcCtD
Cyclophosphamide—Blood bilirubin increased—Docetaxel—head and neck cancer	0.000703	0.00204	CcSEcCtD
Cyclophosphamide—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.000702	0.00204	CcSEcCtD
Cyclophosphamide—Hypoaesthesia—Vinblastine—head and neck cancer	0.000701	0.00203	CcSEcCtD
Cyclophosphamide—Dermatitis bullous—Fluorouracil—head and neck cancer	0.000699	0.00203	CcSEcCtD
Cyclophosphamide—Hearing impaired—Docetaxel—head and neck cancer	0.000698	0.00203	CcSEcCtD
Cyclophosphamide—Stomatitis—Hydroxyurea—head and neck cancer	0.000698	0.00202	CcSEcCtD
Cyclophosphamide—Inflammation—Docetaxel—head and neck cancer	0.000685	0.00199	CcSEcCtD
Cyclophosphamide—Cardiac failure—Fluorouracil—head and neck cancer	0.000685	0.00199	CcSEcCtD
Cyclophosphamide—Respiratory failure—Docetaxel—head and neck cancer	0.000677	0.00196	CcSEcCtD
Cyclophosphamide—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.000669	0.00194	CcSEcCtD
Cyclophosphamide—Pulmonary embolism—Docetaxel—head and neck cancer	0.000665	0.00193	CcSEcCtD
Cyclophosphamide—Haemoglobin—Hydroxyurea—head and neck cancer	0.000646	0.00187	CcSEcCtD
Cyclophosphamide—Influenza like illness—Docetaxel—head and neck cancer	0.000646	0.00187	CcSEcCtD
Cyclophosphamide—Haemorrhage—Hydroxyurea—head and neck cancer	0.000643	0.00186	CcSEcCtD
Cyclophosphamide—Colitis—Docetaxel—head and neck cancer	0.000638	0.00185	CcSEcCtD
Cyclophosphamide—Cardiac arrest—Fluorouracil—head and neck cancer	0.000636	0.00185	CcSEcCtD
Cyclophosphamide—Fluid retention—Docetaxel—head and neck cancer	0.000631	0.00183	CcSEcCtD
Cyclophosphamide—Alopecia—Vinblastine—head and neck cancer	0.000623	0.00181	CcSEcCtD
Cyclophosphamide—Neoplasm—Docetaxel—head and neck cancer	0.000601	0.00174	CcSEcCtD
Cyclophosphamide—Nasopharyngitis—Fluorouracil—head and neck cancer	0.000598	0.00174	CcSEcCtD
Cyclophosphamide—Pulmonary oedema—Docetaxel—head and neck cancer	0.000592	0.00172	CcSEcCtD
Cyclophosphamide—Sepsis—Docetaxel—head and neck cancer	0.000577	0.00167	CcSEcCtD
Cyclophosphamide—Chills—Hydroxyurea—head and neck cancer	0.000577	0.00167	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Vinblastine—head and neck cancer	0.000569	0.00165	CcSEcCtD
Cyclophosphamide—Alopecia—Hydroxyurea—head and neck cancer	0.000568	0.00165	CcSEcCtD
Cyclophosphamide—Anaemia—Vinblastine—head and neck cancer	0.000567	0.00165	CcSEcCtD
Cyclophosphamide—Phlebitis—Docetaxel—head and neck cancer	0.00056	0.00163	CcSEcCtD
Cyclophosphamide—Erythema—Hydroxyurea—head and neck cancer	0.000559	0.00162	CcSEcCtD
Cyclophosphamide—Malaise—Vinblastine—head and neck cancer	0.000553	0.00161	CcSEcCtD
Cyclophosphamide—Leukopenia—Vinblastine—head and neck cancer	0.000549	0.00159	CcSEcCtD
Cyclophosphamide—Pancytopenia—Fluorouracil—head and neck cancer	0.000549	0.00159	CcSEcCtD
Cyclophosphamide—Swelling—Docetaxel—head and neck cancer	0.000547	0.00159	CcSEcCtD
Cyclophosphamide—Deafness—Docetaxel—head and neck cancer	0.000539	0.00157	CcSEcCtD
Cyclophosphamide—Hepatic failure—Docetaxel—head and neck cancer	0.000537	0.00156	CcSEcCtD
Cyclophosphamide—Cardiac failure congestive—Docetaxel—head and neck cancer	0.000532	0.00154	CcSEcCtD
Cyclophosphamide—Convulsion—Vinblastine—head and neck cancer	0.000531	0.00154	CcSEcCtD
Cyclophosphamide—Hypertension—Vinblastine—head and neck cancer	0.00053	0.00154	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000519	0.00151	CcSEcCtD
Cyclophosphamide—Pneumonia—Fluorouracil—head and neck cancer	0.000518	0.0015	CcSEcCtD
Cyclophosphamide—Anaemia—Hydroxyurea—head and neck cancer	0.000517	0.0015	CcSEcCtD
Cyclophosphamide—Discomfort—Vinblastine—head and neck cancer	0.000516	0.0015	CcSEcCtD
Cyclophosphamide—Hot flush—Docetaxel—head and neck cancer	0.000516	0.0015	CcSEcCtD
Cyclophosphamide—Menopausal symptoms—Docetaxel—head and neck cancer	0.000511	0.00148	CcSEcCtD
Cyclophosphamide—Atrial fibrillation—Docetaxel—head and neck cancer	0.000509	0.00148	CcSEcCtD
Cyclophosphamide—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.000508	0.00147	CcSEcCtD
Cyclophosphamide—Renal impairment—Docetaxel—head and neck cancer	0.000507	0.00147	CcSEcCtD
Cyclophosphamide—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000505	0.00147	CcSEcCtD
Cyclophosphamide—Myocardial infarction—Fluorouracil—head and neck cancer	0.000505	0.00147	CcSEcCtD
Cyclophosphamide—Dermatitis bullous—Docetaxel—head and neck cancer	0.000505	0.00147	CcSEcCtD
Cyclophosphamide—Malaise—Hydroxyurea—head and neck cancer	0.000504	0.00146	CcSEcCtD
Cyclophosphamide—Stomatitis—Fluorouracil—head and neck cancer	0.000502	0.00146	CcSEcCtD
Cyclophosphamide—Conjunctivitis—Fluorouracil—head and neck cancer	0.000501	0.00145	CcSEcCtD
Cyclophosphamide—Leukopenia—Hydroxyurea—head and neck cancer	0.000501	0.00145	CcSEcCtD
Cyclophosphamide—Cardiac failure—Docetaxel—head and neck cancer	0.000494	0.00144	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Vinblastine—head and neck cancer	0.00049	0.00142	CcSEcCtD
Cyclophosphamide—Convulsion—Hydroxyurea—head and neck cancer	0.000485	0.00141	CcSEcCtD
Cyclophosphamide—Hyponatraemia—Docetaxel—head and neck cancer	0.000484	0.00141	CcSEcCtD
Cyclophosphamide—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.000483	0.0014	CcSEcCtD
Cyclophosphamide—Agranulocytosis—Fluorouracil—head and neck cancer	0.000481	0.0014	CcSEcCtD
Cyclophosphamide—Anorexia—Vinblastine—head and neck cancer	0.000477	0.00138	CcSEcCtD
Cyclophosphamide—Discomfort—Hydroxyurea—head and neck cancer	0.00047	0.00137	CcSEcCtD
Cyclophosphamide—Haemoglobin—Fluorouracil—head and neck cancer	0.000465	0.00135	CcSEcCtD
Cyclophosphamide—Rhinitis—Fluorouracil—head and neck cancer	0.000464	0.00135	CcSEcCtD
Cyclophosphamide—Haemorrhage—Fluorouracil—head and neck cancer	0.000462	0.00134	CcSEcCtD
Cyclophosphamide—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00046	0.00134	CcSEcCtD
Cyclophosphamide—Oedema—Hydroxyurea—head and neck cancer	0.000456	0.00132	CcSEcCtD
Cyclophosphamide—Infection—Hydroxyurea—head and neck cancer	0.000454	0.00132	CcSEcCtD
Cyclophosphamide—Paraesthesia—Vinblastine—head and neck cancer	0.000449	0.0013	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000447	0.0013	CcSEcCtD
Cyclophosphamide—Anorexia—Hydroxyurea—head and neck cancer	0.000435	0.00126	CcSEcCtD
Cyclophosphamide—Decreased appetite—Vinblastine—head and neck cancer	0.000435	0.00126	CcSEcCtD
Cyclophosphamide—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.000434	0.00126	CcSEcCtD
Cyclophosphamide—Nasopharyngitis—Docetaxel—head and neck cancer	0.000431	0.00125	CcSEcCtD
Cyclophosphamide—Pain—Vinblastine—head and neck cancer	0.000428	0.00124	CcSEcCtD
Cyclophosphamide—Constipation—Vinblastine—head and neck cancer	0.000428	0.00124	CcSEcCtD
Cyclophosphamide—Arrhythmia—Fluorouracil—head and neck cancer	0.000413	0.0012	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Vinblastine—head and neck cancer	0.000412	0.0012	CcSEcCtD
Cyclophosphamide—Bronchospasm—Docetaxel—head and neck cancer	0.00041	0.00119	CcSEcCtD
Cyclophosphamide—Alopecia—Fluorouracil—head and neck cancer	0.000409	0.00119	CcSEcCtD
Cyclophosphamide—Dyspnoea—Hydroxyurea—head and neck cancer	0.000407	0.00118	CcSEcCtD
Cyclophosphamide—Erythema—Fluorouracil—head and neck cancer	0.000403	0.00117	CcSEcCtD
Cyclophosphamide—Decreased appetite—Hydroxyurea—head and neck cancer	0.000397	0.00115	CcSEcCtD
Cyclophosphamide—Pancytopenia—Docetaxel—head and neck cancer	0.000396	0.00115	CcSEcCtD
Cyclophosphamide—Fatigue—Hydroxyurea—head and neck cancer	0.000394	0.00114	CcSEcCtD
Cyclophosphamide—Constipation—Hydroxyurea—head and neck cancer	0.00039	0.00113	CcSEcCtD
Cyclophosphamide—Pain—Hydroxyurea—head and neck cancer	0.00039	0.00113	CcSEcCtD
Cyclophosphamide—Weight increased—Docetaxel—head and neck cancer	0.00038	0.0011	CcSEcCtD
Cyclophosphamide—Vision blurred—Fluorouracil—head and neck cancer	0.000379	0.0011	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000376	0.00109	CcSEcCtD
Cyclophosphamide—Pneumonia—Docetaxel—head and neck cancer	0.000374	0.00109	CcSEcCtD
Cyclophosphamide—Anaemia—Fluorouracil—head and neck cancer	0.000372	0.00108	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Vinblastine—head and neck cancer	0.000369	0.00107	CcSEcCtD
Cyclophosphamide—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000369	0.00107	CcSEcCtD
Cyclophosphamide—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000367	0.00106	CcSEcCtD
Cyclophosphamide—Renal failure—Docetaxel—head and neck cancer	0.000366	0.00106	CcSEcCtD
Cyclophosphamide—Myocardial infarction—Docetaxel—head and neck cancer	0.000364	0.00106	CcSEcCtD
Cyclophosphamide—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000364	0.00106	CcSEcCtD
Cyclophosphamide—Stomatitis—Docetaxel—head and neck cancer	0.000362	0.00105	CcSEcCtD
Cyclophosphamide—Jaundice—Docetaxel—head and neck cancer	0.000362	0.00105	CcSEcCtD
Cyclophosphamide—Conjunctivitis—Docetaxel—head and neck cancer	0.000361	0.00105	CcSEcCtD
Cyclophosphamide—Body temperature increased—Hydroxyurea—head and neck cancer	0.000361	0.00105	CcSEcCtD
Cyclophosphamide—Leukopenia—Fluorouracil—head and neck cancer	0.00036	0.00105	CcSEcCtD
Cyclophosphamide—Asthenia—Vinblastine—head and neck cancer	0.000359	0.00104	CcSEcCtD
Cyclophosphamide—Convulsion—Fluorouracil—head and neck cancer	0.000349	0.00101	CcSEcCtD
Cyclophosphamide—Agranulocytosis—Docetaxel—head and neck cancer	0.000347	0.00101	CcSEcCtD
Cyclophosphamide—Chest pain—Fluorouracil—head and neck cancer	0.000343	0.000995	CcSEcCtD
Cyclophosphamide—Myalgia—Fluorouracil—head and neck cancer	0.000343	0.000995	CcSEcCtD
Cyclophosphamide—Diarrhoea—Vinblastine—head and neck cancer	0.000342	0.000994	CcSEcCtD
Cyclophosphamide—Discomfort—Fluorouracil—head and neck cancer	0.000339	0.000983	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000336	0.000976	CcSEcCtD
Cyclophosphamide—Haemoglobin—Docetaxel—head and neck cancer	0.000335	0.000974	CcSEcCtD
Cyclophosphamide—Rhinitis—Docetaxel—head and neck cancer	0.000335	0.000971	CcSEcCtD
Cyclophosphamide—Haemorrhage—Docetaxel—head and neck cancer	0.000334	0.000969	CcSEcCtD
Cyclophosphamide—Hepatitis—Docetaxel—head and neck cancer	0.000334	0.000969	CcSEcCtD
Cyclophosphamide—Hypoaesthesia—Docetaxel—head and neck cancer	0.000332	0.000964	CcSEcCtD
Cyclophosphamide—Confusional state—Fluorouracil—head and neck cancer	0.000331	0.000962	CcSEcCtD
Cyclophosphamide—Dizziness—Vinblastine—head and neck cancer	0.000331	0.000961	CcSEcCtD
Cyclophosphamide—Oedema—Fluorouracil—head and neck cancer	0.000329	0.000954	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000329	0.000954	CcSEcCtD
Cyclophosphamide—Asthenia—Hydroxyurea—head and neck cancer	0.000328	0.000951	CcSEcCtD
Cyclophosphamide—Infection—Fluorouracil—head and neck cancer	0.000326	0.000947	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000322	0.000934	CcSEcCtD
Cyclophosphamide—Visual impairment—Docetaxel—head and neck cancer	0.000322	0.000934	CcSEcCtD
Cyclophosphamide—Tachycardia—Fluorouracil—head and neck cancer	0.000321	0.000931	CcSEcCtD
Cyclophosphamide—Vomiting—Vinblastine—head and neck cancer	0.000318	0.000924	CcSEcCtD
Cyclophosphamide—Erythema multiforme—Docetaxel—head and neck cancer	0.000316	0.000916	CcSEcCtD
Cyclophosphamide—Headache—Vinblastine—head and neck cancer	0.000314	0.00091	CcSEcCtD
Cyclophosphamide—Anorexia—Fluorouracil—head and neck cancer	0.000313	0.000909	CcSEcCtD
Cyclophosphamide—Diarrhoea—Hydroxyurea—head and neck cancer	0.000312	0.000907	CcSEcCtD
Cyclophosphamide—Flushing—Docetaxel—head and neck cancer	0.00031	0.000899	CcSEcCtD
Cyclophosphamide—Hypotension—Fluorouracil—head and neck cancer	0.000307	0.000891	CcSEcCtD
Cyclophosphamide—Dizziness—Hydroxyurea—head and neck cancer	0.000302	0.000876	CcSEcCtD
Cyclophosphamide—Chills—Docetaxel—head and neck cancer	0.0003	0.000869	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000299	0.000869	CcSEcCtD
Cyclophosphamide—Arrhythmia—Docetaxel—head and neck cancer	0.000298	0.000865	CcSEcCtD
Cyclophosphamide—Nausea—Vinblastine—head and neck cancer	0.000297	0.000863	CcSEcCtD
Cyclophosphamide—Paraesthesia—Fluorouracil—head and neck cancer	0.000295	0.000856	CcSEcCtD
Cyclophosphamide—Alopecia—Docetaxel—head and neck cancer	0.000295	0.000856	CcSEcCtD
Cyclophosphamide—Dyspnoea—Fluorouracil—head and neck cancer	0.000293	0.00085	CcSEcCtD
Cyclophosphamide—Erythema—Docetaxel—head and neck cancer	0.000291	0.000843	CcSEcCtD
Cyclophosphamide—Vomiting—Hydroxyurea—head and neck cancer	0.00029	0.000842	CcSEcCtD
Cyclophosphamide—Rash—Hydroxyurea—head and neck cancer	0.000288	0.000835	CcSEcCtD
Cyclophosphamide—Dermatitis—Hydroxyurea—head and neck cancer	0.000288	0.000835	CcSEcCtD
Cyclophosphamide—Headache—Hydroxyurea—head and neck cancer	0.000286	0.00083	CcSEcCtD
Cyclophosphamide—Decreased appetite—Fluorouracil—head and neck cancer	0.000286	0.000829	CcSEcCtD
Cyclophosphamide—Dysgeusia—Docetaxel—head and neck cancer	0.000285	0.000826	CcSEcCtD
Cyclophosphamide—Pain—Fluorouracil—head and neck cancer	0.000281	0.000816	CcSEcCtD
Cyclophosphamide—Muscle spasms—Docetaxel—head and neck cancer	0.000279	0.000811	CcSEcCtD
Cyclophosphamide—Nausea—Hydroxyurea—head and neck cancer	0.000271	0.000787	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Fluorouracil—head and neck cancer	0.000271	0.000786	CcSEcCtD
Cyclophosphamide—Anaemia—Docetaxel—head and neck cancer	0.000269	0.00078	CcSEcCtD
Cyclophosphamide—Urticaria—Fluorouracil—head and neck cancer	0.000261	0.000758	CcSEcCtD
Cyclophosphamide—Leukopenia—Docetaxel—head and neck cancer	0.00026	0.000755	CcSEcCtD
Cyclophosphamide—Body temperature increased—Fluorouracil—head and neck cancer	0.00026	0.000754	CcSEcCtD
Cyclophosphamide—Palpitations—Docetaxel—head and neck cancer	0.000257	0.000745	CcSEcCtD
Cyclophosphamide—Cough—Docetaxel—head and neck cancer	0.000254	0.000736	CcSEcCtD
Cyclophosphamide—Convulsion—Docetaxel—head and neck cancer	0.000252	0.000731	CcSEcCtD
Cyclophosphamide—Hypertension—Docetaxel—head and neck cancer	0.000251	0.000728	CcSEcCtD
Cyclophosphamide—Arthralgia—Docetaxel—head and neck cancer	0.000247	0.000718	CcSEcCtD
Cyclophosphamide—Myalgia—Docetaxel—head and neck cancer	0.000247	0.000718	CcSEcCtD
Cyclophosphamide—Chest pain—Docetaxel—head and neck cancer	0.000247	0.000718	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Fluorouracil—head and neck cancer	0.000242	0.000703	CcSEcCtD
Cyclophosphamide—Confusional state—Docetaxel—head and neck cancer	0.000239	0.000694	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Docetaxel—head and neck cancer	0.000237	0.000688	CcSEcCtD
Cyclophosphamide—Oedema—Docetaxel—head and neck cancer	0.000237	0.000688	CcSEcCtD
Cyclophosphamide—Infection—Docetaxel—head and neck cancer	0.000236	0.000684	CcSEcCtD
Cyclophosphamide—Shock—Docetaxel—head and neck cancer	0.000233	0.000677	CcSEcCtD
Cyclophosphamide—Pruritus—Fluorouracil—head and neck cancer	0.000232	0.000675	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Docetaxel—head and neck cancer	0.000232	0.000674	CcSEcCtD
Cyclophosphamide—Tachycardia—Docetaxel—head and neck cancer	0.000231	0.000672	CcSEcCtD
Cyclophosphamide—Anorexia—Docetaxel—head and neck cancer	0.000226	0.000656	CcSEcCtD
Cyclophosphamide—Diarrhoea—Fluorouracil—head and neck cancer	0.000225	0.000653	CcSEcCtD
Cyclophosphamide—Hypotension—Docetaxel—head and neck cancer	0.000222	0.000643	CcSEcCtD
Cyclophosphamide—Dizziness—Fluorouracil—head and neck cancer	0.000217	0.000631	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000216	0.000627	CcSEcCtD
Cyclophosphamide—Paraesthesia—Docetaxel—head and neck cancer	0.000213	0.000618	CcSEcCtD
Cyclophosphamide—Dyspnoea—Docetaxel—head and neck cancer	0.000211	0.000614	CcSEcCtD
Cyclophosphamide—Vomiting—Fluorouracil—head and neck cancer	0.000209	0.000606	CcSEcCtD
Cyclophosphamide—Rash—Fluorouracil—head and neck cancer	0.000207	0.000601	CcSEcCtD
Cyclophosphamide—Dermatitis—Fluorouracil—head and neck cancer	0.000207	0.000601	CcSEcCtD
Cyclophosphamide—Decreased appetite—Docetaxel—head and neck cancer	0.000206	0.000598	CcSEcCtD
Cyclophosphamide—Headache—Fluorouracil—head and neck cancer	0.000206	0.000597	CcSEcCtD
Cyclophosphamide—Fatigue—Docetaxel—head and neck cancer	0.000204	0.000593	CcSEcCtD
Cyclophosphamide—Constipation—Docetaxel—head and neck cancer	0.000203	0.000589	CcSEcCtD
Cyclophosphamide—Pain—Docetaxel—head and neck cancer	0.000203	0.000589	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Docetaxel—head and neck cancer	0.000195	0.000567	CcSEcCtD
Cyclophosphamide—Nausea—Fluorouracil—head and neck cancer	0.000195	0.000566	CcSEcCtD
Cyclophosphamide—Body temperature increased—Docetaxel—head and neck cancer	0.000187	0.000544	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Docetaxel—head and neck cancer	0.000175	0.000507	CcSEcCtD
Cyclophosphamide—Asthenia—Docetaxel—head and neck cancer	0.00017	0.000494	CcSEcCtD
Cyclophosphamide—Pruritus—Docetaxel—head and neck cancer	0.000168	0.000487	CcSEcCtD
Cyclophosphamide—Diarrhoea—Docetaxel—head and neck cancer	0.000162	0.000471	CcSEcCtD
Cyclophosphamide—CYP2C18—Biological oxidations—GSTM1—head and neck cancer	0.00016	0.00468	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Biological oxidations—NAT2—head and neck cancer	0.000159	0.00466	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metapathway biotransformation—GSTM1—head and neck cancer	0.000158	0.00462	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metapathway biotransformation—NAT2—head and neck cancer	0.000157	0.0046	CbGpPWpGaD
Cyclophosphamide—Dizziness—Docetaxel—head and neck cancer	0.000157	0.000455	CcSEcCtD
Cyclophosphamide—CYP3A5—Biological oxidations—NAT2—head and neck cancer	0.000156	0.00455	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metapathway biotransformation—NAT2—head and neck cancer	0.000154	0.00449	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000153	0.00447	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Biological oxidations—CYP1A1—head and neck cancer	0.000152	0.00444	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000151	0.00443	CbGpPWpGaD
Cyclophosphamide—Vomiting—Docetaxel—head and neck cancer	0.000151	0.000438	CcSEcCtD
Cyclophosphamide—CYP2C18—Metapathway biotransformation—CYP1A1—head and neck cancer	0.00015	0.00438	CbGpPWpGaD
Cyclophosphamide—Rash—Docetaxel—head and neck cancer	0.00015	0.000434	CcSEcCtD
Cyclophosphamide—Dermatitis—Docetaxel—head and neck cancer	0.000149	0.000434	CcSEcCtD
Cyclophosphamide—Headache—Docetaxel—head and neck cancer	0.000149	0.000431	CcSEcCtD
Cyclophosphamide—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000147	0.00429	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000145	0.00423	CbGpPWpGaD
Cyclophosphamide—Nausea—Docetaxel—head and neck cancer	0.000141	0.000409	CcSEcCtD
Cyclophosphamide—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.00014	0.00411	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000139	0.00408	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000138	0.00404	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000137	0.00401	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Biological oxidations—NAT2—head and neck cancer	0.000135	0.00394	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—UROD—head and neck cancer	0.000133	0.0039	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metapathway biotransformation—NAT2—head and neck cancer	0.000133	0.00389	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000131	0.00383	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000129	0.00378	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Fluoropyrimidine Activity—TP53—head and neck cancer	0.000123	0.00359	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.00012	0.00352	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Biological oxidations—NAT2—head and neck cancer	0.00012	0.00352	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000119	0.00349	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000119	0.00348	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000119	0.00347	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metapathway biotransformation—NAT2—head and neck cancer	0.000119	0.00347	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000118	0.00344	CbGpPWpGaD
Cyclophosphamide—CYP2A6—NRF2 pathway—GSTM1—head and neck cancer	0.000111	0.00325	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Biological oxidations—NAT2—head and neck cancer	0.000111	0.00324	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Biological oxidations—NAT2—head and neck cancer	0.00011	0.00321	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metapathway biotransformation—NAT2—head and neck cancer	0.000109	0.00319	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metapathway biotransformation—NAT2—head and neck cancer	0.000108	0.00317	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Biological oxidations—GSTM1—head and neck cancer	0.000106	0.00311	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000106	0.0031	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metapathway biotransformation—GSTM1—head and neck cancer	0.000105	0.00307	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000101	0.00295	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Biological oxidations—CYP1A1—head and neck cancer	0.000101	0.00295	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metapathway biotransformation—CYP1A1—head and neck cancer	9.95e-05	0.00291	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	9.88e-05	0.00289	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	9.76e-05	0.00285	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Biological oxidations—GSTM1—head and neck cancer	9.75e-05	0.00285	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	9.73e-05	0.00285	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	9.67e-05	0.00283	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Biological oxidations—CYP1A1—head and neck cancer	9.24e-05	0.0027	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Arachidonic acid metabolism—PTGS2—head and neck cancer	9e-05	0.00263	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	8.99e-05	0.00263	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—UROD—head and neck cancer	8.87e-05	0.00259	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Arachidonic acid metabolism—PTGS2—head and neck cancer	8.21e-05	0.0024	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—UROD—head and neck cancer	8.13e-05	0.00238	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	7.87e-05	0.0023	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Biological oxidations—GSTM1—head and neck cancer	7.87e-05	0.0023	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	7.77e-05	0.00227	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metapathway biotransformation—GSTM1—head and neck cancer	7.76e-05	0.00227	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Biological oxidations—GSTM1—head and neck cancer	7.69e-05	0.00225	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metapathway biotransformation—GSTM1—head and neck cancer	7.58e-05	0.00222	CbGpPWpGaD
Cyclophosphamide—ABCB1—Allograft Rejection—CASP8—head and neck cancer	7.48e-05	0.00219	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Biological oxidations—CYP1A1—head and neck cancer	7.46e-05	0.00218	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metapathway biotransformation—CYP1A1—head and neck cancer	7.36e-05	0.00215	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Biological oxidations—CYP1A1—head and neck cancer	7.29e-05	0.00213	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Biological oxidations—NAT2—head and neck cancer	7.24e-05	0.00212	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metapathway biotransformation—CYP1A1—head and neck cancer	7.19e-05	0.0021	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	7.14e-05	0.00209	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Biological oxidations—GSTM1—head and neck cancer	6.66e-05	0.00195	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metapathway biotransformation—GSTM1—head and neck cancer	6.57e-05	0.00192	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—UROD—head and neck cancer	6.56e-05	0.00192	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—UROD—head and neck cancer	6.41e-05	0.00188	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	6.38e-05	0.00187	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Biological oxidations—CYP1A1—head and neck cancer	6.31e-05	0.00185	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metapathway biotransformation—CYP1A1—head and neck cancer	6.23e-05	0.00182	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Biological oxidations—GSTM1—head and neck cancer	5.94e-05	0.00174	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metapathway biotransformation—GSTM1—head and neck cancer	5.86e-05	0.00172	CbGpPWpGaD
Cyclophosphamide—ABCB1—Allograft Rejection—IL2—head and neck cancer	5.65e-05	0.00165	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Biological oxidations—CYP1A1—head and neck cancer	5.64e-05	0.00165	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metapathway biotransformation—CYP1A1—head and neck cancer	5.56e-05	0.00163	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—UROD—head and neck cancer	5.55e-05	0.00162	CbGpPWpGaD
Cyclophosphamide—ABCB1—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	5.54e-05	0.00162	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—NAT2—head and neck cancer	5.54e-05	0.00162	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Biological oxidations—GSTM1—head and neck cancer	5.47e-05	0.0016	CbGpPWpGaD
Cyclophosphamide—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	5.43e-05	0.00159	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	5.42e-05	0.00159	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	5.4e-05	0.00158	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metapathway biotransformation—GSTM1—head and neck cancer	5.39e-05	0.00158	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	5.35e-05	0.00156	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Biological oxidations—CYP1A1—head and neck cancer	5.18e-05	0.00152	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	5.14e-05	0.0015	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metapathway biotransformation—CYP1A1—head and neck cancer	5.11e-05	0.0015	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	5.07e-05	0.00148	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—UROD—head and neck cancer	4.96e-05	0.00145	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—DPYD—head and neck cancer	4.86e-05	0.00142	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—UROD—head and neck cancer	4.84e-05	0.00142	CbGpPWpGaD
Cyclophosphamide—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	4.8e-05	0.0014	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—YAP1—head and neck cancer	4.61e-05	0.00135	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—UROD—head and neck cancer	4.56e-05	0.00133	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—UROD—head and neck cancer	4.52e-05	0.00132	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	4.31e-05	0.00126	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	3.85e-05	0.00113	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	3.69e-05	0.00108	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—NAT2—head and neck cancer	3.68e-05	0.00108	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	3.57e-05	0.00105	CbGpPWpGaD
Cyclophosphamide—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	3.54e-05	0.00103	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	3.53e-05	0.00103	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	3.51e-05	0.00103	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	3.39e-05	0.000991	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—NAT2—head and neck cancer	3.38e-05	0.000988	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	3.34e-05	0.000978	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—DPYD—head and neck cancer	3.23e-05	0.000945	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	3.17e-05	0.000926	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—YAP1—head and neck cancer	3.06e-05	0.000897	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	3.01e-05	0.00088	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—UROD—head and neck cancer	2.98e-05	0.000872	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—DPYD—head and neck cancer	2.96e-05	0.000866	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—YAP1—head and neck cancer	2.81e-05	0.000822	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—TYMS—head and neck cancer	2.77e-05	0.00081	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—GSTM1—head and neck cancer	2.74e-05	0.0008	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—NAT2—head and neck cancer	2.72e-05	0.000797	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	2.72e-05	0.000795	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—NAT2—head and neck cancer	2.66e-05	0.000779	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	2.62e-05	0.000767	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—GPX1—head and neck cancer	2.62e-05	0.000767	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—CYP1A1—head and neck cancer	2.59e-05	0.000759	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.45e-05	0.000716	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.42e-05	0.000709	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—DPYD—head and neck cancer	2.39e-05	0.000699	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	2.37e-05	0.000693	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—DPYD—head and neck cancer	2.33e-05	0.000683	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—NAT2—head and neck cancer	2.31e-05	0.000675	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—YAP1—head and neck cancer	2.27e-05	0.000663	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	2.24e-05	0.000656	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—YAP1—head and neck cancer	2.22e-05	0.000648	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.19e-05	0.000639	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.16e-05	0.000633	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	2.13e-05	0.000624	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	2.13e-05	0.000624	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—NAT2—head and neck cancer	2.06e-05	0.000602	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—DPYD—head and neck cancer	2.02e-05	0.000592	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—NAT2—head and neck cancer	2.01e-05	0.000588	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.99e-05	0.000583	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.97e-05	0.000577	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—YAP1—head and neck cancer	1.92e-05	0.000561	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—NAT2—head and neck cancer	1.89e-05	0.000554	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—NAT2—head and neck cancer	1.88e-05	0.000549	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	1.85e-05	0.000541	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—TYMS—head and neck cancer	1.84e-05	0.000538	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—GSTM1—head and neck cancer	1.82e-05	0.000532	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—DPYD—head and neck cancer	1.8e-05	0.000528	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	1.79e-05	0.000524	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—DPYD—head and neck cancer	1.76e-05	0.000515	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—GPX1—head and neck cancer	1.74e-05	0.00051	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—CYP1A1—head and neck cancer	1.72e-05	0.000504	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—YAP1—head and neck cancer	1.71e-05	0.000501	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—TYMS—head and neck cancer	1.69e-05	0.000493	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—YAP1—head and neck cancer	1.67e-05	0.000489	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—GSTM1—head and neck cancer	1.67e-05	0.000488	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—DPYD—head and neck cancer	1.66e-05	0.000486	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—DPYD—head and neck cancer	1.65e-05	0.000481	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—GPX1—head and neck cancer	1.6e-05	0.000467	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—CYP1A1—head and neck cancer	1.58e-05	0.000462	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—YAP1—head and neck cancer	1.58e-05	0.000461	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—YAP1—head and neck cancer	1.56e-05	0.000457	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—PTGS2—head and neck cancer	1.54e-05	0.000451	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	1.51e-05	0.000442	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.44e-05	0.000422	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—TYMS—head and neck cancer	1.36e-05	0.000398	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—GSTM1—head and neck cancer	1.35e-05	0.000394	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—PTEN—head and neck cancer	1.35e-05	0.000394	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—TYMS—head and neck cancer	1.33e-05	0.000389	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—GSTM1—head and neck cancer	1.31e-05	0.000385	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—GPX1—head and neck cancer	1.29e-05	0.000377	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.29e-05	0.000376	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—CYP1A1—head and neck cancer	1.28e-05	0.000373	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—GPX1—head and neck cancer	1.26e-05	0.000368	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.26e-05	0.000368	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—CYP1A1—head and neck cancer	1.25e-05	0.000365	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—NAT2—head and neck cancer	1.24e-05	0.000362	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.17e-05	0.000343	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—TYMS—head and neck cancer	1.15e-05	0.000337	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—GSTM1—head and neck cancer	1.14e-05	0.000333	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.12e-05	0.000328	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—GPX1—head and neck cancer	1.09e-05	0.000319	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—DPYD—head and neck cancer	1.09e-05	0.000318	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—CYP1A1—head and neck cancer	1.08e-05	0.000316	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—YAP1—head and neck cancer	1.03e-05	0.000301	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—TYMS—head and neck cancer	1.03e-05	0.000301	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—PTGS2—head and neck cancer	1.03e-05	0.0003	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.02e-05	0.000299	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—GSTM1—head and neck cancer	1.02e-05	0.000297	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—TYMS—head and neck cancer	1e-05	0.000294	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—GSTM1—head and neck cancer	9.92e-06	0.00029	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—GPX1—head and neck cancer	9.74e-06	0.000285	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—CYP1A1—head and neck cancer	9.64e-06	0.000282	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—GPX1—head and neck cancer	9.5e-06	0.000278	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—PIK3CA—head and neck cancer	9.49e-06	0.000278	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—TYMS—head and neck cancer	9.46e-06	0.000277	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CYP1A1—head and neck cancer	9.41e-06	0.000275	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PTGS2—head and neck cancer	9.4e-06	0.000275	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—TYMS—head and neck cancer	9.38e-06	0.000274	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—GSTM1—head and neck cancer	9.35e-06	0.000274	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—GSTM1—head and neck cancer	9.27e-06	0.000271	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—GPX1—head and neck cancer	8.95e-06	0.000262	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—PTEN—head and neck cancer	8.94e-06	0.000262	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—GPX1—head and neck cancer	8.88e-06	0.00026	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	8.87e-06	0.000259	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CYP1A1—head and neck cancer	8.86e-06	0.000259	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CYP1A1—head and neck cancer	8.79e-06	0.000257	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PTEN—head and neck cancer	8.2e-06	0.00024	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	7.92e-06	0.000232	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—AKT1—head and neck cancer	7.75e-06	0.000227	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PTGS2—head and neck cancer	7.58e-06	0.000222	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PTGS2—head and neck cancer	7.41e-06	0.000217	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	7.22e-06	0.000211	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PTEN—head and neck cancer	6.61e-06	0.000193	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PTEN—head and neck cancer	6.47e-06	0.000189	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PTGS2—head and neck cancer	6.42e-06	0.000188	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—PIK3CA—head and neck cancer	6.31e-06	0.000185	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—TYMS—head and neck cancer	6.18e-06	0.000181	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—GSTM1—head and neck cancer	6.11e-06	0.000179	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—GPX1—head and neck cancer	5.85e-06	0.000171	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CYP1A1—head and neck cancer	5.8e-06	0.00017	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PIK3CA—head and neck cancer	5.78e-06	0.000169	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PTGS2—head and neck cancer	5.73e-06	0.000168	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PTEN—head and neck cancer	5.6e-06	0.000164	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PTGS2—head and neck cancer	5.59e-06	0.000164	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PTGS2—head and neck cancer	5.27e-06	0.000154	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PTGS2—head and neck cancer	5.23e-06	0.000153	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—AKT1—head and neck cancer	5.15e-06	0.000151	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PTEN—head and neck cancer	5e-06	0.000146	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PTEN—head and neck cancer	4.88e-06	0.000143	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—AKT1—head and neck cancer	4.72e-06	0.000138	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PIK3CA—head and neck cancer	4.67e-06	0.000137	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PTEN—head and neck cancer	4.6e-06	0.000134	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PIK3CA—head and neck cancer	4.56e-06	0.000133	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PTEN—head and neck cancer	4.56e-06	0.000133	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PIK3CA—head and neck cancer	3.95e-06	0.000116	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—AKT1—head and neck cancer	3.81e-06	0.000112	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—AKT1—head and neck cancer	3.73e-06	0.000109	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PIK3CA—head and neck cancer	3.53e-06	0.000103	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PTGS2—head and neck cancer	3.45e-06	0.000101	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PIK3CA—head and neck cancer	3.44e-06	0.000101	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PIK3CA—head and neck cancer	3.24e-06	9.49e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—AKT1—head and neck cancer	3.23e-06	9.44e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PIK3CA—head and neck cancer	3.22e-06	9.41e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PTEN—head and neck cancer	3.01e-06	8.79e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—AKT1—head and neck cancer	2.88e-06	8.43e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—AKT1—head and neck cancer	2.81e-06	8.22e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—AKT1—head and neck cancer	2.65e-06	7.75e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—AKT1—head and neck cancer	2.63e-06	7.68e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PIK3CA—head and neck cancer	2.12e-06	6.2e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—AKT1—head and neck cancer	1.73e-06	5.07e-05	CbGpPWpGaD
